Biotinylated Anti-Bevacizumab Antibody (AY13) (recommended for PK/PD)

Source

Biotinylated Anti-Bevacizumab Antibody (AY13) is a mouse monoclonal antibody derived from hybridoma cells fused with SP2/0 myeloma cells and murine B lymphocytes.

Antibody Type

Hybridoma Monoclonal

Clone

AY13

Isotype

Mouse IgG1, Kappa

Host Species

Mouse

Immunogen

Bevacizumab

Conjugate

Biotin

Specificity

Recognizes Bevacizumab specifically.

Application

Purification

Protein A purified / Protein G purified.

Aggregation

Less than 5%, as determined by SEC-MALS.

Concentration

Please refer to the Certificate of Analysis (CoA).

Form

Lyophilized

Formulation

Lyophilized from a 0.22 μm-filtered solution in PBS (pH 7.4) containing 0.03% PF68, with trehalose as protectant.

Please contact us for customized product forms or formulations.

Reconstitution

Please refer to the Certificate of Analysis (CoA) for specific instructions.

Shipping

Lyophilized product is shipped at ambient temperature.

Storage

For long term storage, the product should be stored in a lyophilized state at -20°C or lower.

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:

1. -20°C to -70°C for 12 months in lyophilized state;
2. -70°C for 12 months under sterile conditions after reconstitution.

Notices

Product Specific Notices: For research use only.

ACRO Quality Management System

1. QMS(ISO, GMP)
2. Quality Advantages
3. Quality Control Process